Pinatuzumab is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody drug conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL).
Purity:
97.0%
CAS Number:
[1639820-81-7]
* VAT and and shipping costs not included. Errors and price changes excepted